 |
|
Possible Concentration-Dependent Suppression of Immune Response by Verapamil
Norbert W. Tietz, PhD;
John Thompson, MD
Arch Fam Med. 1995;4(4):368-369.
References
Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.
| |
1. Birx DL, Berger M, Fleisher TA. The interference of T-cell activation by calcium channel blocking agents. J Immunol. 1984;133:2904-2909.
ABSTRACT
2. Grier CE, Mastro AM. Mitogen and co-mitogen stimulation of lymphocytes inhibited by three Ca+ + antagonists. J Cell Physiol. 1985;124:131-136.
PUBMED
3. McMillen MA, Lewis T, Jaffe BM, Wait RB. Verapamil inhibition of lymphocyte proliferation and function in vitro. J Surg Res. 1985;39:76-80.
PUBMED
4. Wright B, Zeidman I, Greig R, Poste G. Inhibition of macrophage activation by calcium channel blockers and calmodulin antagonists. Cell Immunol. 1985;95:46-53.
PUBMED
5. Levy R, Dana R, Gold B, Alkan M, Schlaeffer F. Influence of calcium channel blockers on polymorphonuclear and monocyte bactericidal and fungicidal activity. Israel J Med Sci. 1991;27:301-306.
PUBMED
6. Weir M, Peppier R, Gomolka D, Handwerger B. Evidence that the antiproliferative effect of verapamil on afferent and efferent immune responses is independent of calcium channel inhibition. Transplantation. 1992;54:681-685.
PUBMED
7. Malec P, Tchörzewski H, Markiewicz K, et al. Effect of a single intravenous dose of verapamil on some immune parameters in duodenal ulcer patients. Pol J Pharmacol Pharm. 1988;40:373-380.
PUBMED
|
